Cello Health PLC operates in the Commercial nonphysical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cello Health PLC with three other
miscellaneous service companies in Europe:
Internationella Engelska Skolan I Sverige Holdings II AB
sales of 2.24 billion Swedish Kronor [US$235.28 million]
EAC Invest AS
(1.60 billion Danish Kroner [US$236.40 million]
of which 61%
was Europe), and
based in France
(187.71 million Euro [US$207.64 million]
Cello Health PLC reported sales of £165.57 million (US$217.57 million)
December of 2018.
decrease of 2.2%
versus 2017, when the company's sales were £169.29 million.
The sales level in 2018 was fairly close to the level five years ago: in 2013, Cello Health PLC had sales
of £159.67 million.
Contributing to the drop in overall sales was the 8.6% decline
in Cello Signal, from £81.91 million to £74.90 million.
However, these declines were partially offset by the increase in sales of
Cello Health (up 3.5% to £88.48 million)
Unallocated Corporate Expenses (up 14.1% to £2.19 million)